[1]
T. Zeppola, “Efficacy of second-line treatment with capecitabine and lapatinib in HER2-positive mammary neoplasia, with encephalic metastasis, after first-line therapy with dual anti-HER2 block: Efficacia in II linea del trattamento con capecitabina e lapatinib nella neoplasia mammaria HER2-positiva, con metastasi encefaliche, dopo I linea con do ”, AboutOpen, vol. 4, no. 1, pp. 62–65, Jun. 2018.